The role of Vδ2+T-cells in patients with active Mycobacterium tuberculosis infection and tuberculin anergy

International Journal of Tuberculosis and Lung Disease

Volumn 12, Issue 3, 2008, Pages 262-268

  Szereday, L ^a   Baliko, Z ^a   Szekeres Bartho, Julia ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Anergy; Human; Mycobacterium tuberculosis; NK cell receptors; V 2+T cells

Indexed keywords

FAS LIGAND; NATURAL KILLER CELL RECEPTOR; PERFORIN; TUBERCULIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE FUNCTION; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; TUBERCULOSIS; CYTOTOXICITY; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TUBERCULOSIS;

EID: 40549086585     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. World Health Organization. The world health report 2004: changing history. Geneva, Switzerland: WHO, 2004.
2. Boussiotis V A, Tsai E Y, Yunis E J, et al. IL-10-producing T-cells suppress immune responses in anergic tuberculosis patients. J Clin Invest 2000; 105: 1317-1325.
3. Bloom W. The role of T-cell subsets in Mycobacterium tuberculosis infection. Infect Agents Dis 1996; 5: 73-81.
4. Carding S R, Egan P J. Gammadelta T-cells: functional plasticity and heterogeneity. Nat Rev Immunol 2002; 2: 336-345.
5. Chen Z W, Letvin N L. Vgamma2Vdelta2+ T-cells and antimicrobial immune response. Microbes Infect 2003; 5: 491-498.
6. Szereday L, Baliko Z, Szekeres-Bartho J. γδ T-cell subsets in patients with active Mycobacterium tuberculosis infection and tuberculin anergy. Clin Exp Immunol 2003; 131: 287-291.
7. Fisch P, Moris A, Rammensee H G, Handgretinger R. Inhibitory MHC class I receptors on γδ T-cells in tumour immunity and autoimmunity. Immunol Today 2000; 4: 187-191.
8. Lafarge X, Pitard V, Ravet S, et al. Expression of MHC class I receptors confers functional intraclonal heterogeneity to a reactive expansion of gammadelta T-cells. Eur J Immunol 2005; 35: 896-905.
9. Moser J M, Gibbs J, Jensen P E, Lukacher A E. CD94-NKG2A receptor regulate antiviral CD8+ T-cell responses. Nat Immunol 2002; 3: 189.
10. Malmberg K J, Levitsky V, Norell H, et al. IFNγ protects short-term ovarian carcinoma cell lines from CTL lysis via CD94/NKG2A-dependent mechanism. J Clin Invest 2002; 110: 1515.
11. Mills K H. Regulatory T-cells: friend or foe in immunity to infection? Nature Reviews 2004; 4: 841-855.
12. Shevach E M. CD4+CD25+ suppressor T-cells: more questions than answers. Nat Rev Immunol 2002; 2: 389-400.
13. Shevach E M. Regulatory T-cells in autoimmunity. Annu Rev Immunol 2000; 18: 423-449.
14. Baecher-Allan C, Brown J A, Freeman G J, Hafler D A. CD4+ CD25high regulatory cells in human peripheral blood. J Immunol 2001; 167: 1245-1253.
15. McGuirk P, McCann C, Mills K H. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dentritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J Exp Med 2002; 195: 221-231.
16. MacDonald A J, Duffy M, Brady M T, et al. CD4 T helper type 1 and regulatory T-cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons. J Infect Dis 2002; 185: 720-727.
17. Weiss L, Donkova-Petrini V, Caecavelli L, Balbo M, Carbonneil C, Levy Y. Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T-cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 2004; 104: 3249-3256.
18. Belkaid Y, Piccirillo C A, Mendez S, Shevach E M, Sacks D L. CD4+CD25+ regulatory T-cells control Leishmania major persistence and immunity. Nature 2002; 420: 502-507.
19. Belkaid Y. Regulatory T-cells and infection: a dangerous necessity. Nat Rev Immunol 2007; 7: 875-888.
20. Canaday D H, Wilkinson R J, Li Q, Harding C V, Silver R F, Boom W H. CD4+ and CD8+ T-cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanisms. J Immunol 2001; 167: 2734-2742.
21. Li B, Bassiri H, Rossman M D, et al. Involvement of the Fas/Fas ligand pathway in activation-induced cell death of mycobacteria-reactive human γδ T-cells in patients with pulmonary tuberculosis. J Immunol 1998; 161: 1558-1567.
22. Griffith G M, Mueller C. Expression of perforin and granzymes in vivo: potential markers for activated cytotoxic cells. Immunol Today 1991; 12: 415-419.
23. Podack E R, Hengartner H, Lichtenheld M G. A central role of perforin in cytolysis? Annu Rev Immunol 1991; 9: 129-157.
24. Rojas E R, Chervenak K A, Thomas J, et al. Vδ2+ γδ T-cell function in Mycobacterium tuberculosis- and HIV-1-positive patients in the United States and Uganda: application of a whole-blood assay. J Infect Dis 2005; 192: 1806-1814.
25. Yi H, Zhen Y, Jiang L, Zheng J, Zhao Y. The phenotypic characterization of naturally occuring regulatory CD4 + CD25+ T-cells. Cell Mol Immunol 2006; 3: 189-195.
26. Moretta L, Moretta A. Unravelling natural killer cell function: triggering and inhibitory human NK receptors. Embo J 2004; 23: 255-259.
27. Moretta L, Biassoni R, Bottino C, Mingari M C, Moretta A. Human NK-cell receptors. Immunol Today 2000; 21: 420-422.
28. Arlettaz L, Villard J, de Rham C, et al. Activating CD94: NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR alphabeta lymphocytes. Eur J Immunol 2004; 34: 3456-3464.
29. Morris A, Rothenfusser S, Meuer E, Hangretinger R, Fisch P. Role of gammadelta T-cells in tumor immunity and their control by NK receptors. Microbes Infect 1999; 3: 227-234.
30. Lodoen M B, Lanier L L. Natural killer cells as an initial defense against pathogens. Curr Opin Immunol 2006; 18: 391-398.